GPI welcomes new Commercial Development Manager to rapidly growing UK team
Sam Fieldwick joins GPI, as part of the Commercial Development team
GPI are pleased to announce and welcome Sam Fieldwick as the new Commercial Development Manager. Sam will be responsible for working with existing and new clients, driving revenue for GPI and the growth of our Commercial activities.
Sam has previously worked as a Commercial Validation Manager, working with life science partners and drug developers to build, provide, and commercialise databases. His experience focuses on research intelligence, and analytical support for the developmental strategy of Preclinical to Clinical, and Commercially available Assets.
“I’m really excited to join GPI at what seems a really important time in the industry. I’m really looking forward to getting started and to provide the pharmaceutical industry with data driven rationale to underpin pricing and market access decisions.”
With a wealth of experience supporting the pharmaceutical industry, Sam joins GPI at a critical time as we work with our partners and clients to provide innovative solutions and services to the BioPharma industry.
GPI is a market leader in analytics and innovative solutions for biopharma pricing, market access and commercial strategy. Headquartered London, with offices in Cambridge and Mumbai, GPI support price decision-making throughout the lifecycle and help the industry achieve day-to-day operational improvement and market access excellence.
As a team of leading domain specialists, GPI provide high quality, curated insights and recommendations on global drug pricing strategy, market access optimisation, asset evaluation, value perception and payer behaviour.
GPI’s suite of technology and bespoke service offerings are powered by GPI pulse™, a solution that harnesses the power of technology, data, and collective expertise to drive effective and efficient access to medicines with faster insights and sustainable pricing strategies.